Alkali Metal Or Alkaline Earth Containing Patents (Class 424/722)
  • Publication number: 20130058954
    Abstract: The present invention relates to methods of diagnosis and treatment of corneal ectasia following refractive surgery, keratoconus or pellucid marginal degeneration in a subject by determining or modulating the level of expression of molecules associated with the Wnt signalling pathway. Marker molecules of the present invention include SFRP1, PITX2, LEF1, WNT16 and WNT5A.
    Type: Application
    Filed: December 2, 2010
    Publication date: March 7, 2013
    Applicant: THE UNIVERSITY OF SYDNEY
    Inventors: Gerard Sutton, John McAvoy, Michele Madigan
  • Publication number: 20130052280
    Abstract: The use of theobromine for lowering central blood pressure and/or lowering central pulse pressure in humans and derived benefits, and compositions comprising theobromine.
    Type: Application
    Filed: January 18, 2011
    Publication date: February 28, 2013
    Inventors: Richard Draijer, Bas Van Den Bogaard
  • Publication number: 20130052248
    Abstract: An item of clothing (10) for daily pharmacological treatment of a fungal infection, comprising: a textile material (20) to manage moisture when the item of clothing (10) is worn; microcapsules (30) grafted on the textile material (20); and antifungal agents encapsulated within the microcapsules (30) to pharmacologically treat the fungal infection when released from the microcapsules (30).
    Type: Application
    Filed: August 26, 2011
    Publication date: February 28, 2013
    Inventors: Marcus Chun Wah YUEN, Joanne Yiu Wan YIP, Kevin CHEUK, Chi Wai KAN, Shuk Yan CHENG
  • Publication number: 20130052281
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1 and R2 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: August 22, 2012
    Publication date: February 28, 2013
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: William FARNABY, Charlotte FIELDHOUSE, Catrina KERR, Natasha KINSELLA, David LIVERMORE, Kevin MERCHANT, David MILLER, Katherine HAZEL
  • Publication number: 20130045183
    Abstract: The present disclosure relates to non-acidic extracts or fractions selected from a Boswellia low polar gum resin extract fraction (BLPRE), a Boswellia volatile oil fraction (BVOIL), and a Boswellia oil fraction (BOIL) and their compositions. BLPRE, BOIL, and BVOIL are each derived from the gum resin of a Boswellia species. These compositions are useful for improving mental condition, enhancing brain functions such as cognition, memory, learning, communication and brain health, for treating impaired memory, and for preventing, control or treating memory and cognition related disorders/diseases. Additionally, BOIL, BVOIL, and mixtures of BOIL and BVOIL are useful for enhancing the bioavailability of a biological agent.
    Type: Application
    Filed: September 14, 2012
    Publication date: February 21, 2013
    Applicant: LAILA NUTRACEUTICALS
    Inventors: Ganga Raju GOKARAJU, Rama Raju GOKARAJU, Venkata Kanaka Ranga Raju GOKARAJU, Trimurtulu GOLAKOTI, Kiran BHUPATHIRAJU, Venkata Krishna Raju ALLURI
  • Publication number: 20130045247
    Abstract: The presently described technology provides a novel class of prodrugs of quetiapine that can be synthesized by chemically conjugating fatty acids to quetiapine. Pharmaceutical compositions and methods of synthesizing conjugates of the present technology are also provided. Methods of treating patients with the compositions of the present technology are also provided.
    Type: Application
    Filed: March 9, 2011
    Publication date: February 21, 2013
    Inventors: Travis Mickle, Sven Guenther, Sanjib Bera
  • Patent number: 8372444
    Abstract: A composition comprises an ion-exchanged carrageenan. The carrageenan may be a traditionally extracted or neutrally extracted iota or kappa carrageenan. The ion-exchanged carrageenan has reduced gelling cation contents, reduced gelling temperature, and reduced melting temperature, as compared to its non-ion-exchanged counterpart. The ion-exchanged carrageenan may be mixed with another carrageenan to form a carrageenan product having a unique gelling temperature and melting temperature. Also disclosed is a process for making an ion-exchanged carrageenan composition.
    Type: Grant
    Filed: September 5, 2012
    Date of Patent: February 12, 2013
    Assignee: CP Kelco U.S., Inc.
    Inventor: Jens Eskil Trudsoe
  • Publication number: 20130004594
    Abstract: Disclosed are oral rehydration compositions with sucrose, or alternatively fructose and glucose in a 1:1 ratio. The composition further comprises an osmolarity of below 250 mOsm/L, and sodium below 75 meq/L. Further disclosed are methods of treatment using the same.
    Type: Application
    Filed: July 1, 2011
    Publication date: January 3, 2013
    Applicant: Drip Drop, Inc.
    Inventor: Eduardo P. Dolhun
  • Publication number: 20130004588
    Abstract: Compositions and methods for treating and/or preventing conditions such as diaper rash and atopic dermatitis are disclosed. The compositions and methods are particularly useful in the treatment and prevention of diaper rash and diaper dermatitis caused by the prolonged contact of human skin with body waste. The methods employ the topical application of a trypsin-inhibiting agent to the area in need of such treatment, or the area where prevention is desired. The trypsin-inhibiting agent is preferably a divalent cation.
    Type: Application
    Filed: June 28, 2011
    Publication date: January 3, 2013
    Inventors: Connie B. Lin, Euen Thomas Graham Ekman Gunn, Ya-Ping Hu, Neema Kulkarni, Mary Catherine Mack
  • Publication number: 20120321725
    Abstract: Provided is a method of preparing a red clay processed material using red clay and sodium hydroxide and a red clay processed material having anti-corrosive and virus disinfecting activity. Also, a method of preparing alkali ionized water having excellent anti-bacterial, virus disinfecting and anti-corrosive activity using the red clay processed material, alkali ionized water using the same, and a functional product including the same are provided. The red clay processed material and the method of preparing alkali ionized water using the same can reduce the reaction temperature and reaction time compared to a conventional process, thereby significantly reducing the production cost.
    Type: Application
    Filed: February 3, 2010
    Publication date: December 20, 2012
    Applicant: DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Jung-Keug Park, Moon Young Yoon
  • Publication number: 20120315310
    Abstract: The present invention is based on that local administration of lithium ions in bone tissue has been found to improve the bone formation and bone mass upon implantation of a bone tissue implant in said bone tissue. In particular, the invention relates to a bone tissue implant having an implant surface covered by an oxide layer comprising lithium ions and a method for the manufacture thereof. A blasting powder comprising lithium ions, a method for locally increasing bone formation, and the use of lithium ions or a salt thereof for manufacturing a pharmaceutical composition for locally increasing bone formation are also provided by the present invention.
    Type: Application
    Filed: August 21, 2012
    Publication date: December 13, 2012
    Applicant: Astra Tech AB
    Inventors: Stig HANSSON, Ingela Petersson
  • Patent number: 8329227
    Abstract: The present invention provides formulas for producing compositions for the structural/functional nutritional support for those who struggle with poor focus, concentration and/or memory. In addition, the present invention provides compositions comprising nutritional/botanical factors helpful to those who subjectively experience transient mental fatigue or poor cognitive function. The compositions of this invention consist primarily of the following ingredients B-complex vitamins, antioxidants, minerals, phosphatidyl serine (PS), choline, dimenthyl-aminoethanol (DMAE), docosahexaenoic acid (DHA), L-pyroglutamic acid, as well as herbal extracts from Bacopa monniera, Vinca minor, and Huperzia serrata. The present invention also relates to the administration of these compounds to alleviate mental fatigue or poor cognitive function.
    Type: Grant
    Filed: December 7, 2004
    Date of Patent: December 11, 2012
    Assignee: Factor Nutrition Labs, LLC
    Inventor: Kyl L. Smith
  • Patent number: 8332028
    Abstract: This invention provides new and novel devices and methods for administering lithium (Li) ions to a mammalian subject, especially delivery of the lithium (Li) ions to a body component for example across a body or tissue surface such as skin or a mucosal membrane, or for the delivery of the lithium ions directly to bodily fluids in a controllable and reproducible manner. In certain embodiments the device comprises a donor electrode that is a donor of the lithium ions; a protective architecture that is ionically conductive to the lithium ions, configured for application to a skin surface and positioned to isolate said donor electrode from the skin surface; and a counter electrode configured for application to the skin surface, where said counter electrode is operably coupled to said donor electrode.
    Type: Grant
    Filed: November 28, 2007
    Date of Patent: December 11, 2012
    Assignee: PolyPlus Battery Company
    Inventors: Steven J. Visco, Yevgeniy S. Nimon, Bruce Katz
  • Publication number: 20120283099
    Abstract: The invention disclosed in this document concerns controlling planthoppers.
    Type: Application
    Filed: May 4, 2012
    Publication date: November 8, 2012
    Applicant: DOW AGROSCIENCES LLC
    Inventors: Agamananda Roy, Sanjoy Kundu, Suresh Ramachandran
  • Publication number: 20120282307
    Abstract: A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
    Type: Application
    Filed: July 19, 2012
    Publication date: November 8, 2012
    Applicant: Depomed, Inc.
    Inventors: Bret Berner, Sui Yuen Eddie Hou, Gloria M. Gusler
  • Patent number: 8303996
    Abstract: A barium sulfate-based powder is produced by bringing barium ions (A) into contact with sulfate ions (B) in the presence of one or more metallic ion species (C) selected from the group consisting of lithium ions, sodium ions, potassium ions, magnesium ions, calcium ions, zinc ions, and aluminum ions. Thus, barium sulfate-based powders having various characteristics and thus satisfying functional requirements for cosmetics can be obtained.
    Type: Grant
    Filed: March 7, 2002
    Date of Patent: November 6, 2012
    Assignee: Shiseido Company, Ltd.
    Inventors: Tsuyoshi Miyamoto, Katsuki Ogawa, Sadaki Takata, Mitsuhiro Denda
  • Publication number: 20120276168
    Abstract: The presently described technology provides a novel class of prodrugs of quetiapine that can be synthesized bu chemically conjugating amino acids to quetiapine. The present technology also provides methods of treating patients, pharmaceutical compositions and methods of synthesizing conjugates of the present technology.
    Type: Application
    Filed: December 22, 2010
    Publication date: November 1, 2012
    Inventors: Travis Mickle, Sven Guenther, Sanjib Bera
  • Patent number: 8293285
    Abstract: A composition comprises an ion-exchanged carrageenan. The carrageenan may be a traditionally extracted or neutrally extracted iota or kappa carrageenan. The ion-exchanged carrageenan has reduced gelling cation contents, reduced gelling temperature, and reduced melting temperature, as compared to its non-ion-exchanged counterpart. The ion-exchanged carrageenan may be mixed with another carrageenan to form a carrageenan product having a unique gelling temperature and melting temperature. Also disclosed is a process for making an ion-exchanged carrageenan composition.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: October 23, 2012
    Assignee: CP Kelco U.S., Inc.
    Inventor: Jens Eskil Trudsoe
  • Publication number: 20120251450
    Abstract: Of the many compositions and methods provided herein, one composition includes a nanoparticle having a first oxide of a first metal and a dopant that includes an ion or an atom of a second metal. A method includes a method comprising providing a plurality of nanoparticles comprising a first oxide of a first metal and a dopant that comprises an ion or an atom of a second metal; providing a diseased cell and a healthy cell; contacting the diseased cell and the healthy cell with the nanoparticle; and allowing the nanoparticle to preferentially associate with the diseased cell.
    Type: Application
    Filed: April 4, 2011
    Publication date: October 4, 2012
    Inventors: Alex Punnoose, Denise Wingett
  • Patent number: 8273378
    Abstract: Dialysis solutions comprising pyrophosphates and methods of making and using the dialysis solutions are provided. In an embodiment, the present disclosure provides a dialysis solution comprising a stable and therapeutically effective amount of pyrophosphate. The dialysis solution can be sterilized, for example, using a technique such as autoclave, steam, high pressure, ultra-violet, filtration or combination thereof. The dialysis solution can be in the form of a concentrate.
    Type: Grant
    Filed: January 14, 2010
    Date of Patent: September 25, 2012
    Assignees: Baxter International, Inc., Baxter Healthcare S.A.
    Inventors: Bruce L. Riser, Paul Zieske, Sujatha Karoor, Himanshu D. Patel
  • Patent number: 8273364
    Abstract: A method for treating diseased plants, such as turf and trees, includes mixing a quantity of a plant remediation composition with water and applying the plant remediation composition to the diseased plants. The plant remediation composition may include from about 70 up to about 90 volume percent of a potassium silicate, up to 10 volume percent of a sodium silicate, from about 0.25 to about 3.0 volume percent of a surfactant, from about 0.25 to about 3.0 volume percent of a polyol, and the remaining volume percent water. The plant remediation composition may be used to treat plant molds, bacteria and fungi, such as Anthracnose, Fairy Ring, Brown Patch, Dollar Spot, and Snow Mold, and may also be used to prevent and remediate insect infestations.
    Type: Grant
    Filed: March 24, 2009
    Date of Patent: September 25, 2012
    Inventors: Louis Jack Norman, Kelly Green
  • Patent number: 8273380
    Abstract: A beverage for minimizing or reducing jet lag symptoms preferably includes vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin D, zinc, calcium, iodine, magnesium, manganese, ginseng, ginkgo biloba, grape seed extract, Echinacea extract and water. A method for minimizing or reducing jet lag symptoms including ingestion of the beverage by a traveler, one hour prior to a flight, and/or during the flight, and/or after a flight.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: September 25, 2012
  • Publication number: 20120237443
    Abstract: The present invention is directed to a novel poly (diol citrates)-based coating for implantable devices. More specifically, the specification describes methods and compositions for making and using implantable devices coated with citric acid copolymers or citric acid copolymers impregnated with therapeutic compositions and/or cells.
    Type: Application
    Filed: December 6, 2011
    Publication date: September 20, 2012
    Applicant: Northwestern University
    Inventors: Guillermo Ameer, Jian Yang
  • Publication number: 20120237651
    Abstract: A method of reducing the contamination amount of mycotoxin in cereals wherein one or more compounds A selected from the group consisting of ammonium salts, primary to quaternary ammonium salts, alkali metal salts, alkaline earth metal salts and polyvalent metal salts of phosphorous acid and phosphite ester are given to the cereals.
    Type: Application
    Filed: June 8, 2012
    Publication date: September 20, 2012
    Applicants: Hokusan Co., Ltd, Mitsui Chemicals Agro, Inc.
    Inventors: Daisuke Awakura, Kiyoshi Kimura, Kazuyoshi Masuda
  • Publication number: 20120231092
    Abstract: Treatment regimens for mood disorders that include administration of buprenorphine, alone or in combination with additional pharmacological agents are described. Specifically, treatment regimens that alleviate racing thoughts associated with bipolar disorder, and pharmaceutical compositions and kits for use therein are described. Dosing regimens, compositions, and kits including buprenorphine for treating mania associated with opioid withdrawal are also described.
    Type: Application
    Filed: March 14, 2012
    Publication date: September 13, 2012
    Applicant: ComGenRx, Inc.
    Inventors: Bryan T. Oronsky, Neil C. Oronsky
  • Publication number: 20120231089
    Abstract: A method for reversing stress-induced dysfunctions of a human autonomic nervous system in accordance with Methylation Priority Principle includes repeatedly administering a methylation-promoting composition composed to promote a hierarchy of methylation functions of the Methylation Priority Principle including uninterrupted methylation cycle recycling of homocysteine to methionine, and uninterrupted processing and removal of metabolic products of stress.
    Type: Application
    Filed: April 26, 2012
    Publication date: September 13, 2012
    Inventor: Alan Robert Vinitsky
  • Publication number: 20120219635
    Abstract: A bioactive tissue scaffold is fabricated from glass fiber that forms a rigid three-dimensional porous matrix having a bioactive composition. Porosity in the form of interconnected pore space is provided by the pore space between the glass fiber in the porous matrix. Mechanical properties such as strength, elastic modulus, and pore size distribution is provided by the three-dimensional matrix that is formed by bonded overlapping and intertangled fibers. The bioactive tissue scaffold can be formed from raw materials that are not bioactive, but rather precursors to bioactive materials. The bioactive tissue scaffold supports tissue in-growth to provide osteoconductivity as a resorbable tissue scaffold, used for the repair of damaged and/or diseased bone tissue.
    Type: Application
    Filed: May 3, 2011
    Publication date: August 30, 2012
    Applicant: BIO2 TECHNOLOGIES, INC.
    Inventor: James Jenq Liu
  • Publication number: 20120201908
    Abstract: The disclosure provides methods of treating bipolar disorder by administering an antiestrogen to reduce the severity and frequency of mood episodes. The disclosure further provides methods of treating depression with an antiestrogen in a descending dose protocol.
    Type: Application
    Filed: August 12, 2010
    Publication date: August 9, 2012
    Applicant: Lunera Equities, LLLP
    Inventor: Kirk Patrick Miller
  • Publication number: 20120195984
    Abstract: Described herein are compounds (including medical foods, pharmaceutical compositions, methods of compounding them), methods and systems for the diagnosis and/or treatment of prodromal schizophrenia. For example, described herein are methods of treating a developmentally-based neuropsychiatric disorder (schizophrenia) that includes first determining if a subject is at risk for such a disorder by examining phenotypical, serological immune markers and genotypical biomarkers. The biomarkers may be used to tailor the dose to be delivered by the medial food or pharmaceutical composition. Also described are compounds for treating prodromal (rather than full-blown) schizophrenia.
    Type: Application
    Filed: February 2, 2012
    Publication date: August 2, 2012
    Inventor: Jay L. Lombard
  • Publication number: 20120195974
    Abstract: The invention disclosed in this document concerns controlling mealybugs.
    Type: Application
    Filed: January 27, 2012
    Publication date: August 2, 2012
    Applicant: DOW AGROSCIENCES LLC
    Inventors: Mayank Yadav, Suresh Ramachandran, Sanjoy Kundu
  • Publication number: 20120195985
    Abstract: The present invention provides compounds that are glycine transporter 1 (hereinafter referred to as GlyT-1) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of GlyT-1 such as cognitive disorders associated with Schizophrenia, ADHD (attention deficit hyperactivity disorder), MCI (mild cognitive impairment), and the like. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
    Type: Application
    Filed: March 21, 2012
    Publication date: August 2, 2012
    Applicant: Amgen Inc.
    Inventors: Stephen Hitchcock, Albert Amegadzie, Wenyuan Qian, Xiaoyang Xia, Scott S. Harried
  • Publication number: 20120189718
    Abstract: A pharmaceutical composition for dissolving and eliminating wart and excrescence consisting of protein is disclosed in the present invention. The pharmaceutical composition comprises (in 100 weight parts) 1.0-60.0 parts of sodium hydroxide and/or potassium hydroxide. The pharmaceutical composition further comprises 0.25-1.0 parts of tetracaine, bufalin, venenum bufonis and/or menthol having local anesthetic effect. The pharmaceutical composition can dissolve and eliminate wart and excrescence consisting of protein immediately and has significant effect and low side effect.
    Type: Application
    Filed: June 7, 2010
    Publication date: July 26, 2012
    Inventors: Kuok Leong Tam, Io Cheng Tam, Io Man Tam
  • Publication number: 20120189709
    Abstract: Disclosed are methods of treating an individual having a condition characterized by an imbalance in type 1 and type 2 cytokine production, wherein the method comprises administering to the individual an amount of ?-hydroxy-?-methylbutyrate (HMB) effective to modulate or otherwise cause an increase in the ratio of type 1 to type 2 cytokines, including an increase in the ratio of type 1 to type 2 cytokines without a corresponding increase in type 2 cytokine levels. Also disclosed are methods of using HMB to treat asthma and allergies. The methods of the present invention are based upon the discovery that HMB modulates cytokine production, most typically by increasing type 1 cytokines without a corresponding increase in type 2 cytokines.
    Type: Application
    Filed: January 11, 2012
    Publication date: July 26, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Debra L. Thomas, Pradip Mukerji
  • Publication number: 20120181230
    Abstract: The invention relates to the production of a concentrate for dialysis, the composition of which can be adapted individually to the respective needs of the patient. To do so, the special components required individually are added in the form of highly concentrated special concentrates with a volume of 10-500 mL to 3-10 liters of standard concentrate. The two solutions are then mixed thoroughly by compressed air, which is blown through the concentrate intake rod into the solution from a compressed air source in the dialysis machine.
    Type: Application
    Filed: January 9, 2012
    Publication date: July 19, 2012
    Inventor: Peter Kloeffel
  • Publication number: 20120177750
    Abstract: Topical formulations containing aqueous-soluble divalent strontium cation in a suitable topical keratinized skin formulation vehicle, and methods of using these formulations to inhibit skin irritation in keratinized skin, are disclosed.
    Type: Application
    Filed: March 21, 2012
    Publication date: July 12, 2012
    Inventors: Gary S. HAHN, David O. Thueson
  • Publication number: 20120177744
    Abstract: Disclosed are methods of treating an individual having a condition characterized by an imbalance in type 1 and type 2 cytokine production, wherein the method comprises administering to the individual an amount of ?-hydroxy-?-methylbutyrate (HMB) effective to modulate or otherwise cause an increase in the ratio of type 1 to type 2 cytokines, including an increase in the ratio of type 1 to type 2 cytokines without a corresponding increase in type 2 cytokine levels. Also disclosed are methods of using HMB to treat asthma and allergies. The methods of the present invention are based upon the discovery that HMB modulates cytokine production, most typically by increasing type 1 cytokines without a corresponding increase in type 2 cytokines.
    Type: Application
    Filed: January 11, 2012
    Publication date: July 12, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Debra L. Thomas, Pradip Mukerji
  • Publication number: 20120171156
    Abstract: Conventional commercial hair dyes form potent allergens and may also have irritant properties. If they were not already well established in the market and the side effects tolerated by consumers they would likely be deemed unsafe for use. The invention relates to compounds, compositions, formulations and methods for reducing, avoiding or eliminating allergic contact dermatitis reactions to conventional commercial hair dyes.
    Type: Application
    Filed: June 17, 2010
    Publication date: July 5, 2012
    Inventors: David Basketter, John McFadden, Ian White
  • Publication number: 20120157976
    Abstract: The present invention generally relates to methods, compositions and materials for treatment of and promotion of neurological functional recovery from neurological conditions including central nervous system injuries and/or diseases.
    Type: Application
    Filed: December 20, 2011
    Publication date: June 21, 2012
    Inventors: Stephen Davies, Kenneth Hal Minor
  • Publication number: 20120141598
    Abstract: The invention relates to a composition for decontaminating a toxin present in a polar or non-polar matrix. The composition includes (a) at least one activator that generates reactive oxygen species when reacted with an oxygen radical donator, and (b) at least one oxygen radical donator to react with the activator to create reactive oxygen species. The composition may also include one or more oxidizing agents that include reactive oxygen species.
    Type: Application
    Filed: May 22, 2009
    Publication date: June 7, 2012
    Inventor: Jessie Kater
  • Publication number: 20120134919
    Abstract: A method for formation of spherical particles of ion substituted calcium phosphate. The method is based on precipitation of particles from a buffered solution under static, stirring or hydrothermal conditions. Also, the use of the formed materials and the particles in itself.
    Type: Application
    Filed: August 4, 2010
    Publication date: May 31, 2012
    Applicant: BIOMATCELL AB
    Inventors: Hakan Engqvist, Wei Xia
  • Publication number: 20120128735
    Abstract: A method of treatment for epilepsy and other disease states is described, which comprises delivery of gabapentin in a gastric retained dosage form.
    Type: Application
    Filed: November 21, 2011
    Publication date: May 24, 2012
    Applicant: DEPOMED, INC.
    Inventors: Bret BERNER, Sui Yuen Eddie HOU
  • Publication number: 20120121731
    Abstract: A method for electrolytically generating a biocide having an electron deficient carrier fluid and chlorine dioxide, including providing a carrier fluid; providing a pair of electrodes interposed by a semi-permeable membrane within a vessel for creating a first passageway and a second passageway, an anode electrode of the pair of electrodes disposed in the first passageway, cathode electrode of the pair of electrodes disposed in the second passageway; flowing the carrier fluid through the vessel; applying an electric potential to the pair of electrodes to produce an oxidative acidic fluid, a reductive alkaline fluid, and anodic gases in the container; removing the fluids and gases from the vessel; mixing a portion of the anodic gases with the reductive alkaline fluid to produce a hypochlorite solution; and mixing a chlorite brine with the hypochlorite solution, followed by the introduction of additional oxidative acidic fluid to release the biocide.
    Type: Application
    Filed: November 16, 2010
    Publication date: May 17, 2012
    Inventors: Michael J. Peters, David D. Faulder, John D. Breedlove, S. Robert Mayer
  • Publication number: 20120121724
    Abstract: The present invention is related to the composition and methods of manufacture of orally-dissolvable, edible films as a vehicle for the non-invasive administration of nitroglycerin, as well as other therapeutic agents either with or without nitroglycerin, through the mucosal tissues of the oral cavity. The films include a water soluble film-forming polymer such as pullulan. Methods for producing the films are also disclosed.
    Type: Application
    Filed: January 20, 2012
    Publication date: May 17, 2012
    Inventor: Todd Maibach
  • Publication number: 20120114743
    Abstract: Transdermal compositions containing castor oil are described. The compositions comprise ricinoleic acid and a transdermal vehicle with optional additional agents. One optional additional agent is an adrenergic drug which may cause the ricinoleic acid to penetrate the skin more deeply and have a longer lasting effect. The compositions can be used for treating a variety of ailments traditionally treated with castor oil or castor oil packs, without the mess and inconvenience of using castor oil packs.
    Type: Application
    Filed: January 17, 2012
    Publication date: May 10, 2012
    Inventor: Keith Delprete
  • Patent number: 8173154
    Abstract: A method and compositions for wound care management comprising a dressing comprising a three-dimensional body of glass-based fibers comprising 40 to 80 weight % B2O3, wherein at least 25 wt. % of the fibers have a diameter between 200 nm and 4000 nm, and a length:width aspect ratio of at least 10. The glasses may also be used for wound care as fibers formed into sutures, as particles in surgical glue to close a wound, or as particles in an ointment or cream to apply to a wound. The compositions may comprise glass formers P2O5 and/or SiO2; alkali oxides selected from Li2O, Na2O, K2O, and Rb2O; and/or alkaline earth oxides selected from MgO, SrO, BaO and CaO. The compositions may further comprise 0.05 to 10 wt. % of one or more trace elements selected from Ag, Cu, F, Fe, Mn, Mo, Ni, Sr, and Zn.
    Type: Grant
    Filed: January 6, 2010
    Date of Patent: May 8, 2012
    Assignee: The Curators of the University of Missouri
    Inventors: Steven B. Jung, Delbert E. Day
  • Patent number: 8173175
    Abstract: The present invention consists of the discovery about an ammoniacal solution of sodium azide (NaN3) or other azide salts that in low concentrations induces the budding of grapevine buds and potentially other deciduous fruit trees with the same efficiency as H2CN2 makes.
    Type: Grant
    Filed: December 6, 2006
    Date of Patent: May 8, 2012
    Assignee: Universidad De Chile
    Inventors: Francisco Javier Perez Correa, Juan Ormeno Nunez
  • Publication number: 20120107410
    Abstract: The present invention relates to a product obtained from gastropod spawn, to be used to prepare dermatological, cosmetic or cosmeceutical compositions designed for skin care; said product has the capacity to activate and mobilise skin stem cells, as well as prevent the loss thereof that takes place as a consequence of chronological and premature ageing. The present invention also relates to the process followed in order to obtain said product.
    Type: Application
    Filed: January 28, 2010
    Publication date: May 3, 2012
    Applicant: Industrial Farmaceutica Cantabria, S.A.
    Inventors: Marta Dominguez Valdes-Hevia, Aurora Brieva Delgado, Salvador Gonzalez Rodriguez, Eduardo Reyes Martin, Jose Carballeira Morado, Ernesto Quintana Gonzalez, Juan Pablo Pivel Ranieri, Antonio Guerrero Gomez-Pamo, Angeles Juarranz De La Fuente, Jesus Espada Regalado, Francisco Sanz Rodriguez
  • Publication number: 20120100230
    Abstract: Certain exemplary embodiments can provide a system, machine, device, manufacture, circuit, composition of matter, and/or user interface adapted for and/or resulting from, and/or a method and/or machine-readable medium comprising machine-implementable instructions for, activities that can comprise and/or relate to, applying a treatment composition comprising or derived from a molecular matrix-residing chlorine dioxide composition.
    Type: Application
    Filed: October 4, 2011
    Publication date: April 26, 2012
    Applicant: DHARMA IP, LLC
    Inventors: Kenneth Harrison, Robert Cooke
  • Patent number: 8147855
    Abstract: Methods for inhibiting sensory responses in the skin such as pain and itch using topical formulations containing aqueous-soluble divalent strontium cation in a suitable topical keratinized skin formulation vehicle are disclosed.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: April 3, 2012
    Assignee: Cosmederm Bioscience, Inc.
    Inventors: Gary S. Hahn, David O. Thueson
  • Patent number: 8143309
    Abstract: A composition and method are described for sanitizing or otherwise treating a material such as a non-living surface, living tissue, soil or atmosphere which may be contaminated by a toxin, chemical warfare agent, insect, prion, microorganism or other infectious agent. The composition generally includes an aqueous composition mixture that includes: (a) lower alkanol; (b) an alkalinating agent, and (c) a fatty acid salt and/or ester. The components are present in an effective amount to sanitize (or treat) a material (or modifying a chemical contained thereon) to which the composition is applied. Also described are methods of making the composition.
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: March 27, 2012
    Assignee: UrthTech, LLC
    Inventor: Aziz C. Awad